Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

High Systolic BP, LDL at a Young Age Matter Later in Life

News Daily News

High Systolic BP, LDL at a Young Age Matter Later in Life

December 26, 2023

AHA Selects 2023’s Leading Cardiovascular Research

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

December 22, 2023

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

News Daily News

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

December 06, 2023

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

News Daily News

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

Michael O'Riordan

November 29, 2023

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

November 20, 2023

Mortality Risk Varies Among Patients With Very High LDL Levels

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

November 08, 2023

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

Screen for Hypertensive Disorders During Every Prenatal Visit: USPSTF

News Daily News

Screen for Hypertensive Disorders During Every Prenatal Visit: USPSTF

Michael O'Riordan

September 25, 2023

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

News Daily News

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

September 25, 2023

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

News Daily News

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

September 07, 2023

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

August 23, 2023

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

News Daily News

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

August 22, 2023

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

August 18, 2023

Study Finds No Increased Risk of CVD Years After Infertility Therapies

News Daily News

Study Finds No Increased Risk of CVD Years After Infertility Therapies

August 11, 2023

Cuff(SZ) Trial Published: One Size Does Not Fit All for BP Accuracy

News Daily News

Cuff(SZ) Trial Published: One Size Does Not Fit All for BP Accuracy

August 08, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.